Saliva Test Breakthrough Could Revolutionise Early Stomach Cancer Detection
Groundbreaking research from China suggests a simple saliva test could one day detect stomach cancer at its earliest stages, potentially saving thousands of lives by avoiding invasive diagnostic procedures. Also known as gastric cancer, this disease is often linked to bacterial infections in the stomach, but until now, scientists remained uncertain about which specific bacteria trigger cancerous changes or how these organisms initially colonise the stomach.
Alarming Statistics and Current Diagnostic Challenges
Every year, approximately 6,700 people in the United Kingdom receive a stomach cancer diagnosis, with roughly 3,600 fatalities occurring during the same period. Currently, the disease is typically diagnosed through endoscopy—an invasive procedure where a small camera is threaded through the mouth into the stomach to search for cancerous signs. This method often detects the cancer at advanced stages when treatment options are limited and survival rates are poor.
Chinese Research Identifies Key Bacterial Culprits
Researchers from Shanghai Jiao Tong University School of Medicine have made a significant breakthrough by analysing over 400 saliva and stool samples from gastric cancer patients. Their study, published in the prestigious journal Cell Reports Medicine, identified 23 species of bacteria consistently present in the stomachs of these patients. Crucially, 20 of these bacterial species were also found in the mouths of the same patients, suggesting these organisms begin their life cycle in the oral cavity before migrating to the stomach.
Dr. Fang Jingyuan, the lead researcher and a stomach cancer expert, explained that these bacteria likely cause a dangerous build-up of acid in the stomach, leading to cancerous changes in the lining. The most probable mechanism involves initial infection with Helicobacter pylori (H. pylori), a bacterium responsible for approximately 40 percent of UK stomach cancer cases. H. pylori inflames the stomach lining and weakens the immune system's ability to clear subsequent infections, allowing oral bacteria to establish persistent infections that eventually trigger cancerous transformations.
The Promise of Non-Invasive Screening
The research team argues that their findings could lead to the development of a nationwide stomach cancer screening programme using inexpensive, easy-to-administer saliva tests. Early computer modelling based on their microbial signatures suggests such a programme could correctly identify early-stage stomach cancer in nearly 90 percent of cases. This represents a dramatic improvement over current diagnostic methods that often catch the disease too late for effective intervention.
Writing in their published paper, the researchers concluded: 'Our microbial signatures are robust predictors, with oral models outperforming gut ones—suggesting earlier or more pronounced oral alterations. By framing non-Hp opportunists, our findings advance mechanistic understanding and nominate biomarkers for diagnostics and microbiome-targeted therapies in gastric cancer.'
Expert Caution and Validation Requirements
While the findings show tremendous promise, independent experts emphasize that further research and validation are necessary before a clinical saliva test can be developed. Professor Gary Moran, an oral health expert at Dublin Dental University Hospital, commented: 'The saliva of the cancer patients could predict the presence of gastric cancer. This could be useful but requires validation in other cohorts.'
Symptoms and Survival Statistics
According to Cancer Research UK, stomach cancer symptoms include loss of appetite, difficulty swallowing, persistent indigestion, and unexplained fatigue. Unfortunately, these symptoms are often dismissed by patients, leading to late diagnoses. The survival rates for stage 4 stomach cancer—the most advanced stage—are particularly bleak, with only about 20 percent of UK patients surviving one year or more after diagnosis.
Other known risk factors for stomach cancer include smoking, heavy alcohol consumption, and poor dietary habits. The disease is twice as common in men as in women, according to epidemiological research. The potential saliva test breakthrough offers hope for earlier detection when treatment is most effective, potentially transforming outcomes for thousands of patients annually.
